Sensei Biotherapeutics Overview

  • Founded
  • 1999
Founded
  • Status
  • Public
  • Employees
  • 23
Employees
  • Stock Symbol
  • SNSE
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $4.86
  • (As of Tuesday Closing)

Sensei Biotherapeutics General Information

Description

Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The companies ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused and coordinated innate and adaptive immune response.

Contact Information

Formerly Known As
Panacea Pharmaceuticals
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Biotechnology
Stock Exchange
NAS
Primary Office
  • 1405 Research Boulevard
  • Suite 125
  • Rockville, MD 20850
  • United States
+1 (240) 000-0000

Sensei Biotherapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sensei Biotherapeutics Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.86 $4.96 $4.56 - $26.50 $152M 30.6M 86.7K -$1.45

Sensei Biotherapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 159,860
Revenue 0 0 0 0
EBITDA (32,181) (18,202) (14,411) (12,668)
Net Income (32,559) (20,100) (16,740) (13,039)
Total Assets 161,249 21,428 1,217 1,850
Total Debt 0 567 16,055 4,746
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sensei Biotherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sensei Biotherapeutics‘s full profile, request access.

Request a free trial

Sensei Biotherapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Sensei Biotherapeutics‘s full profile, request access.

Request a free trial

Sensei Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of
Drug Discovery
Rockville, MD
23 As of 2021
00000
0000 0000-00-00
00000000 00000

0000000

uip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum d
0000 000000000
Cambridge, MA
00 As of 0000
00000
00000000 00000

000000

ommodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fu
0000 000000000
Rochester, MN
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sensei Biotherapeutics Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oncorus Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
000000 Venture Capital-Backed Rochester, MN 00 000.00 00000000000 000.00
000000000 Formerly VC-backed Woburn, MA 000 00000 00000000 00000
00000000 Formerly VC-backed Mainz, Germany 0000 00.000 00000000 00.000
000000 Formerly VC-backed Ghent, Belgium 000 00000 000000&0 00000
You’re viewing 5 of 5 competitors. Get the full list »

Sensei Biotherapeutics Patents

Sensei Biotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200345820-A1 Combination therapies for cancer Pending 01-May-2019 0000000000000
EP-3866841-A1 Compositions and methods for manufacturing bacteriophage cancer vaccines and uses thereof Pending 19-Oct-2018 0000000000000
US-20200121773-A1 Compositions and methods for manufacturing bacteriophage cancer vaccines and uses thereof Pending 19-Oct-2018 0000000000000
US-20190345261-A1 Aspartate beta-hydroxylase chimeric antigen receptors and uses thereof Abandoned 10-May-2018 000000000
US-20200390902-A1 Antibody-drug conjugates targeted at human aspartyl-(asparaginyl)-b-hydroxylase (haah) Abandoned 22-Aug-2017 A61K47/6871
To view Sensei Biotherapeutics’s complete patent history, request access »

Sensei Biotherapeutics Executive Team (11)

Name Title Board Seat Contact Info
John Celebi Chief Executive Officer & Board Member
Robert Pierce MD Chief Research & Development Officer
Hossein Ghanbari Ph.D Co-Founder, Chairman & Chief Science Officer
Erin Colgan Chief Financial Officer
Lora Pike Vice President, Investor Relations & Communications
You’re viewing 5 of 11 executive team members. Get the full list »

Sensei Biotherapeutics Board Members (19)

Name Representing Role Since
Alain Algazi Self Board Observer 000 0000
Daniel Sterman Self Board Observer 000 0000
Deneen Vojta MD Self Board Member 000 0000
James Peyer Ph.D Cambrian Board Member 000 0000
Jessie English Ph.D Sensei Biotherapeutics Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Sensei Biotherapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sensei Biotherapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sensei Biotherapeutics‘s full profile, request access.

Request a free trial

Sensei Biotherapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 19-May-2020 0000000000 Biotechnology 0000 0000
To view Sensei Biotherapeutics’s complete acquisitions history, request access »